X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (265) 265
Publication (39) 39
Paper (4) 4
Patent (4) 4
Book Chapter (3) 3
Conference Proceeding (3) 3
Book / eBook (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (125) 125
hematology (102) 102
index medicus (93) 93
male (82) 82
female (81) 81
adult (68) 68
middle aged (64) 64
aged (54) 54
adolescent (45) 45
oncology (43) 43
transplantation (34) 34
child (30) 30
treatment outcome (28) 28
survival (25) 25
iron overload (22) 22
risk factors (22) 22
therapy (22) 22
cancer (21) 21
stem cells (21) 21
young adult (20) 20
bone marrow transplantation (19) 19
aged, 80 and over (18) 18
thalassemia (18) 18
bone marrow (17) 17
risk (17) 17
analysis (16) 16
bone-marrow-transplantation (16) 16
chemotherapy (16) 16
immunology (16) 16
iron (16) 16
acute myeloid-leukemia (15) 15
care and treatment (15) 15
child, preschool (15) 15
stem-cell transplantation (15) 15
disease-free survival (14) 14
cyclophosphamide (13) 13
hematopoietic stem cell transplantation (13) 13
hematopoietic stem cells (13) 13
leukemia (13) 13
myelodysplastic syndrome (13) 13
myelodysplastic syndromes (13) 13
patients (13) 13
prognosis (13) 13
retrospective studies (13) 13
beta-thalassemia - therapy (12) 12
health aspects (12) 12
hematology, oncology and palliative medicine (12) 12
stem cell transplantation (12) 12
thalassemia - therapy (12) 12
time factors (12) 12
transplantation, homologous (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
classification (11) 11
deferasirox (11) 11
follow-up studies (11) 11
italy (11) 11
recurrence (11) 11
research (11) 11
rituximab (11) 11
survival analysis (11) 11
survival rate (11) 11
transplants & implants (11) 11
case-control studies (10) 10
combined modality therapy (10) 10
iron chelating agents - therapeutic use (10) 10
medicine, general & internal (10) 10
remission induction (10) 10
versus-host-disease (10) 10
beta-thalassemia (9) 9
chelation therapy (9) 9
disease (9) 9
epidemiology (9) 9
infant (9) 9
lymphoma (9) 9
medical research (9) 9
multivariate analysis (9) 9
overload (9) 9
prospective studies (9) 9
anemia (8) 8
animals (8) 8
chelation (8) 8
clinical medicine (8) 8
cyclophosphamide - therapeutic use (8) 8
hematopoietic stem cell transplantation - methods (8) 8
liver (8) 8
lymphomas (8) 8
management (8) 8
medical and health sciences (8) 8
medicin och hälsovetenskap (8) 8
medicine, experimental (8) 8
mortality (8) 8
thalassemia major (8) 8
trial (8) 8
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
biopsy (7) 7
chelation-therapy (7) 7
hematopoietic stem cell transplantation - adverse effects (7) 7
klinisk medicin (7) 7
liver - metabolism (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 03/2019, Volume 133, Issue 12, pp. 1267 - 1268
In this issue of Blood, Piga et al report results of a phase 2, open label, nonrandomized, uncontrolled dose-finding study evaluating the effects of... 
STEM-CELL | HEMATOLOGY | ACE-536 | ERYTHROPOIESIS
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2019, Volume 19, pp. S75 - S76
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 03/2016, Volume 1368, Issue 1, pp. 115 - 121
Journal Article
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 2010, Volume 2010, Issue 1, pp. 456 - 462
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 1, pp. 22 - 33
Journal Article
Journal Article
Blood Reviews, ISSN 0268-960X, 01/2018, Volume 32, Issue 1, pp. 29 - 35
Iron, although essential, is harmful in high amounts. Oxidative stress as a result of excess reactive oxygen species (ROS) and a prooxidative/antioxidative... 
Clonal evolution | Haematopoietic stem cells | Oxidative stress | Iron | LIFE-SPAN | STEM-CELLS | DNA-DAMAGE | SELF-RENEWAL | RISK MYELODYSPLASTIC SYNDROME | LABILE PLASMA IRON | ACUTE MYELOID-LEUKEMIA | CHELATION-THERAPY | HYDROGEN-PEROXIDE | TRANSFUSION-DEPENDENT PATIENTS | HEMATOLOGY
Journal Article
Journal Article
Internal and Emergency Medicine, ISSN 1828-0447, 12/2018, Volume 13, Issue 8, pp. 1191 - 1200
As a consequence of population aging, we have witnessed in internal medicine hospital wards a progressive shift from a population of in-patients relatively... 
Polypharmacy | Medicine & Public Health | Medication reconciliation | Inappropriate prescription | Internal Medicine | Deprescribing | Multimorbidity | Chronic diseases | Neurosciences | Aged | Medicine | Aging | Internal medicine | Elderly | Patients
Journal Article
The Lancet Oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
The prognosis of young patients with diffuse large B-cell lymphoma at high risk (age-adjusted International Prognostic Index [aa-IPI] score 2 or 3) treated... 
CLINICAL-PRACTICE GUIDELINES | SURVIVAL | SUPPORT | IMPACT | CONSOLIDATION | RESPONSE CRITERIA | ONCOLOGY | R-CHOP | NON-HODGKIN-LYMPHOMA | ELDERLY-PATIENTS | MEGACHOEP | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Transplantation, Autologous | Consolidation Chemotherapy | Cyclophosphamide - adverse effects | Lymphoma, Large B-Cell, Diffuse - therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Hematologic Diseases - chemically induced | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisone - adverse effects | Risk Factors | Etoposide - administration & dosage | Survival Rate | Cytarabine - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Intention to Treat Analysis | Vincristine - adverse effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Carmustine - administration & dosage | Stem Cell Transplantation - adverse effects | Stem cells
Journal Article